Access cutting-edge acute pancreatitis treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access acute pancreatitis specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related acute pancreatitis treatment provided free
The goal of this clinical trial is to test the safety and effectiveness of a single dose of RABI-767 given by endoscopic ultrasound (EUS) guided peripancreatic injection in participants with predicted severe acute pancreatitis. The main question the study aims to answer is: • Is a single-dose of RABI-767 given by EUS-guided peripancreatic injection safe in patients with predicted severe acute pancreatitis. The study also aims to answer: • Is a single-dose of RABI-767 given by EUS-guided peri
Sponsor: Panafina, Inc.
Check if you qualify for this acute pancreatitis clinical trial in Chicago, IL
If you're searching for acute pancreatitis treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced acute pancreatitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.